COM:ADAPTIMMUNE
Adaptimmune Therapeutics plc
- Stock
Last Close
0.66
21/11 21:00
Market Cap
293.91M
Beta: -
Volume Today
780.14K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 51.11K - | 51.11K 0% | 1.88M 3,578.61% | 2.42M 28.91% | 1.27M 47.47% | 1.77M 39.24% | 1.04M 41.16% | 639.50K - | |||
average payables | 1.46M - | 1.50M 2.20% | 6.66M 345.34% | 9.86M 48.00% | 6.23M 36.84% | 5.22M 16.22% | 6.37M 22.09% | 7.25M 13.78% | 6.43M 11.28% | 6.44M 0.12% | |
average receivables | 1.40M - | 3.67M 161.85% | 3.46M 5.57% | 843K 75.66% | 199K 76.39% | -633.50K 418.34% | -660K 4.18% | 445.50K 167.50% | 4.09M 818.86% | 4.13M 0.84% | |
book value per share | 0.01 - | 7.25 127,752.41% | 2.35 67.65% | 2.31 1.66% | 2.54 9.83% | 1.18 53.54% | 2.40 103.35% | 1.32 44.81% | 0.51 61.58% | 0.00 99.99% | |
capex per share | -0.00 - | -0.14 4,083.66% | -0.18 26.50% | -0.28 57.47% | -0.05 83.00% | -0.03 39.42% | -0.02 30.35% | -0.06 176.29% | -0.18 227.34% | ||
capex to depreciation | -5.79 - | -6.97 20.43% | -3.89 44.20% | -4.61 18.54% | -0.60 86.93% | -0.38 36.34% | -0.38 0.29% | -1.34 249.42% | -4.90 266.12% | ||
capex to operating cash flow | -0.04 - | 0.16 500.90% | 0.27 70.07% | 0.46 73.49% | 0.05 90.21% | 0.03 39.42% | 0.05 98.46% | -0.82 1,609.32% | 0.21 125.63% | ||
capex to revenue | -2.40 - | -0.48 80.12% | -0.90 88.96% | -0.66 26.58% | -0.08 88.03% | -2.74 3,362.80% | -0.73 73.20% | -1.43 94.50% | -1.10 23.29% | ||
cash per share | 0.12 - | 7.95 6,482.16% | 2.56 67.74% | 2.37 7.62% | 2.11 11.06% | 0.85 59.50% | 2.58 202.99% | 2.37 8.22% | 1.27 46.49% | 0.00 99.99% | |
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | 1.14K - | 185.39 83.74% | 38.05 79.48% | 1.99 94.78% | 1.18 40.74% | -474.63 40,400.89% | 12.82 102.70% | 44.64 248.24% | 99.96 123.94% | 4.97 95.03% | |
debt to assets | 0.07 - | 0.14 - | 0.05 62.52% | 0.05 3.20% | 0.07 29.35% | 0.09 27.27% | |||||
debt to equity | 0.10 - | 0.21 - | 0.07 66.25% | 0.12 77.95% | 0.28 127.93% | 0.64 126.60% | |||||
dividend yield | |||||||||||
earnings yield | -0.00 - | -0.03 1,660.80% | -0.25 658.59% | -0.12 52.18% | -0.17 42.85% | -1.09 538.44% | -0.17 84.44% | -0.27 59.71% | -0.70 159.81% | -0.00 99.98% | |
enterprise value | 6.74B - | 426.86M 93.67% | 127.90M 70.04% | 627.61M 390.69% | 628.37M 0.12% | 101.01M 83.93% | 734.71M 627.38% | 459.79M 37.42% | 150.41M 67.29% | 956.59B 635,903.16% | |
enterprise value over ebitda | -477.71 - | -19.55 95.91% | -1.84 90.59% | -8.34 353.36% | -8.43 1.04% | -0.77 90.90% | -5.84 661.77% | -2.95 49.43% | -0.95 67.75% | -8.30K 871,535.75% | |
ev to operating cash flow | 181.14 - | -13.04 107.20% | -2.66 79.64% | -11.56 335.16% | -6.02 47.91% | -0.90 85.09% | -13.71 1,427.03% | 42.85 412.59% | -1.06 102.48% | -6.79K 639,916.56% | |
ev to sales | 11.15K - | 39.81 99.64% | 9.01 77.37% | 16.59 84.15% | 10.56 36.34% | 90.02 752.52% | 185.63 106.19% | 74.77 59.72% | 5.54 92.59% | 15.87K 286,328.79% | |
free cash flow per share | 0.08 - | -1.06 1,355.32% | -0.86 18.58% | -0.90 4.76% | -1.12 24.18% | -1.10 1.70% | -0.40 63.98% | 0.01 103.15% | -1.06 8,609.36% | -0.00 99.99% | |
free cash flow yield | 0.01 - | -0.06 1,195.75% | -0.21 268.50% | -0.14 36.49% | -0.19 44.27% | -0.92 371.00% | -0.07 91.98% | 0.00 104.53% | -0.73 21,956.22% | -0.00 99.98% | |
graham net net | -0.00 - | 6.91 703,130.91% | 1.61 76.66% | 1.50 6.87% | 1.81 20.25% | 0.30 83.51% | 1.82 511.28% | 0.68 62.45% | -0.23 133.43% | -0.00 99.97% | |
graham number | 0.06 - | 9.92 15,959.46% | 7.31 26.36% | 6.44 11.93% | 7.48 16.21% | 5.88 21.32% | 7.02 19.21% | 5.49 21.69% | 3.42 37.66% | 0.00 99.99% | |
income quality | -2.59 - | 1.38 153.34% | 0.67 51.29% | 0.77 15.08% | 1.09 41.13% | 0.82 24.95% | 0.41 49.78% | -0.07 116.47% | 0.86 1,362.54% | 1.24 44.39% | |
intangibles to total assets | 0 - | 0.00 Infinity% | 0.01 814.92% | 0.00 12.05% | 0.01 11.93% | 0.01 127.46% | 0.00 68.33% | 0.00 44.46% | 0.00 36.90% | 0.00 13.11% | |
interest coverage | -2.11K - | 45.39 102.15% | -36.17 - | -219.06 505.61% | 162.99 - | ||||||
interest debt per share | 0.00 - | -0.01 88,643.65% | 0.23 1,736.01% | 0.03 89.09% | 0.00 84.78% | 0.24 6,182.20% | 0.17 31.38% | 0.16 1.79% | 0.14 16.24% | 0.00 99.98% | |
inventory turnover | |||||||||||
invested capital | 0.10 - | 0.21 - | 0.07 66.25% | 0.12 77.95% | 0.28 127.93% | 0.64 126.60% | |||||
market cap | 6.80B - | 655.92M 90.35% | 286.68M 56.29% | 587.44M 104.91% | 559.99M 4.67% | 125.96M 77.51% | 767.88M 509.62% | 584.27M 23.91% | 235.36M 59.72% | 956.71B 406,382.95% | |
net current asset value | 979.32K - | 254.04M 25,840.25% | 130.38M 48.68% | 152.02M 16.60% | 201.24M 32.38% | 62.58M 68.90% | 288.24M 360.56% | 151.87M 47.31% | 8.33M 94.51% | -35.55M 526.68% | |
net debt to ebitda | 3.63 - | 10.49 188.91% | 2.28 78.23% | -0.53 123.38% | -0.92 71.75% | 0.19 120.65% | 0.26 39.22% | 0.80 203.27% | 0.54 32.71% | 1.03 91.57% | |
net income per share | -0.03 - | -0.60 1,917.22% | -1.01 67.61% | -0.80 21.13% | -0.98 22.97% | -1.31 33.24% | -0.91 30.12% | -1.01 11.12% | -1.03 1.15% | -0.00 99.99% | |
operating cash flow per share | 0.09 - | -0.91 1,143.58% | -0.68 25.62% | -0.62 9.23% | -1.07 73.54% | -1.07 0.00% | -0.38 64.90% | 0.07 118.31% | -0.88 1,377.09% | -0.00 99.99% | |
payables turnover | |||||||||||
receivables turnover | 0.32 - | 1.97 515.05% | 9.59 387.26% | 183.66 1,814.42% | 309.92 68.75% | -0.77 100.25% | 28.47 3,802.74% | 8.18 71.28% | 3.65 55.34% | 73.42 1,910.85% | |
research and ddevelopement to revenue | 20.72 - | 2.16 89.56% | 4.49 107.69% | 2.31 48.59% | 1.65 28.50% | 86.90 5,162.03% | 23.13 73.38% | 18.07 21.91% | 4.70 73.96% | 2.10 55.39% | |
return on tangible assets | -0.23 - | -0.07 68.60% | -0.31 327.15% | -0.25 18.32% | -0.35 38.43% | -0.76 120.41% | -0.29 62.15% | -0.34 16.56% | -0.50 49.29% | -0.40 19.92% | |
revenue per share | 0.00 - | 0.30 20,945.80% | 0.20 33.05% | 0.43 114.49% | 0.61 42.02% | 0.01 98.25% | 0.03 159.92% | 0.04 42.05% | 0.17 326.71% | 0.00 99.97% | |
roe | -5.27 - | -0.08 98.42% | -0.43 418.08% | -0.35 19.80% | -0.39 11.96% | -1.11 186.76% | -0.38 65.64% | -0.77 101.33% | -2.02 163.27% | -2.88 42.61% | |
roic | -5.27 - | -0.08 98.46% | -0.40 398.67% | -0.40 0.94% | -0.34 16.15% | -0.80 139.18% | -0.34 57.15% | -0.63 84.69% | -1.30 104.85% | -1.27 2.70% | |
sales general and administrative to revenue | 4.51 - | 1.06 76.60% | 1.63 54.77% | 0.82 49.70% | 0.73 10.88% | 38.67 5,177.93% | 11.57 70.08% | 9.32 19.45% | 2.33 74.95% | 1.22 47.77% | |
shareholders equity per share | 0.01 - | 7.25 127,752.41% | 2.35 67.65% | 2.31 1.66% | 2.54 9.83% | 1.18 53.54% | 2.40 103.35% | 1.32 44.81% | 0.51 61.58% | 0.00 99.99% | |
stock based compensation to revenue | 0.58 - | 0.39 31.85% | 0.62 57.88% | 0.29 54.04% | 0.27 4.65% | 9.85 3,518.03% | 2.63 73.29% | 3.35 27.51% | 0.67 79.97% | 0.20 70.93% | |
tangible asset value | 2.41M - | 259.43M 10,664.83% | 164.87M 36.45% | 201.65M 22.30% | 245.41M 21.70% | 121.44M 50.52% | 339.50M 179.56% | 204.96M 39.63% | 81.44M 60.27% | 39.18M 51.88% | |
tangible book value per share | 0.01 - | 7.25 127,664.90% | 2.33 67.87% | 2.29 1.55% | 2.52 9.89% | 1.16 54.09% | 2.38 105.98% | 1.32 44.80% | 0.51 61.60% | 0.00 99.99% | |
working capital | 979.32K - | 268.35M 27,301.44% | 158.48M 40.94% | 155.87M 1.65% | 206.66M 32.58% | 86.15M 58.31% | 359.08M 316.82% | 352.92M 1.72% | 190.87M 45.92% | 134.76M 29.39% |
All numbers in (except ratios and percentages)